PW Medtech : EXTENSION OF LONG STOP DATE IN RELATION TO THE DISPOSAL OF CBPO SHARES

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

PW MEDTECH GROUP LIMITED

普 華 和 順 集 團 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1358)

EXTENSION OF LONG STOP DATE IN RELATION

TO THE DISPOSAL OF CBPO SHARES

References are made to the circular of PW Medtech Group Limited (the ''Company'') dated October 18, 2019 and the announcement of the Company dated September 19, 2019 (the ''Announcement'') in relation to, among others, the Disposal. Unless otherwise specified, capitalized terms used herein shall have the same meanings as those defined in the Announcement.

As disclosed in the Announcement, in the event that, among others, the closing shall not have occurred within six months from the date of the Share Purchase Agreement, i.e. March 18, 2020 (the ''Long Stop Date''), the Company or Centurium (as the case may be) may terminate the Share Purchase Agreement.

As additional time is required to satisfy the conditions precedent of the Share Purchase Agreement, the Board announces that after good and valuable consideration, the Company and Centurium entered into the amendment No. 1 to Share Purchase Agreement on March 17, 2020 to extend the Long Stop Date to June 30, 2020 (which date may be extended by the parties to the Share Purchase Agreement in writing).

Save as disclosed above, all other provisions of the Share Purchase Agreement continue unmodified.

As the completion of the Disposal is subject to the satisfaction and/or waiver (where applicable) of the conditions precedent set out in the Share Purchase Agreement, the Disposal may or may not materialize. Shareholders and investors are advised to exercise caution when dealing in the securities of the Company.

By order of the Board

PW Medtech Group Limited

Yue'e Zhang

Chairman & Chief Executive Officer

Beijing, the PRC, March 17, 2020

As at the date of this announcement, the Board comprises one executive Director, namely, Ms. Yue'e Zhang; two non- executive Directors, namely, Mr. Jaing Liwei and Mr. Lin Junshan; and three independent non-executive Directors, namely, Mr. Wang Xiaogang, Mr. Zhang Xingdong and Mr. Chen Geng.